Neumora Therapeutics (NMRA) Operating Expenses (2022 - 2026)
Neumora Therapeutics (NMRA) reported Operating Expenses of $42.19 million for Q2 2026, down 21.9% from $54.04 million a year earlier and down 20.2% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Operating Expenses (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Neumora Therapeutics' Operating Expenses came in at $211.23 million, down 20.2% year-over-year; for FY2025, it came in at $241.16 million, down 8.5% from FY2024.
- Operating Expenses has a three-year compound annual growth rate of 21.1% (FY2022 to FY2025).
- By year, Operating Expenses came in at $263.46 million in FY2024 (+4.5%), $252.1 million in FY2023 (+85.5%) and $135.87 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Operating Expenses since Q2 2023.
- Year over year, Operating Expenses has now declined in each of the last five quarters, with an average decline of 10.8% over the last eight quarters.
- The high point for year-over-year Operating Expenses in five years was Q4 2023 (growth of 271.1%); the low point was Q4 2024 (a decline of 44.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $52.86 million (Q1 2026), $58.48 million (Q4 2025) and $57.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 15.99 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 11.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 11.14 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.53 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.00 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 6.66 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.84 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.09 Bn |
| 10 | Neumora Therapeutics | 88.31 Mn | -529.65 Mn | - | 42.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.19 Mn |
| Mar 31, 2026 | 52.86 Mn |
| Dec 31, 2025 | 58.48 Mn |
| Sep 30, 2025 | 57.70 Mn |
| Jun 30, 2025 | 54.04 Mn |
| Mar 31, 2025 | 70.94 Mn |
| Dec 31, 2024 | 62.92 Mn |
| Sep 30, 2024 | 76.65 Mn |
| Jun 30, 2024 | 63.82 Mn |
| Mar 31, 2024 | 60.07 Mn |
| Dec 31, 2023 | 114.00 Mn |
| Sep 30, 2023 | 56.86 Mn |
| Jun 30, 2023 | 42.06 Mn |
| Mar 31, 2023 | 39.17 Mn |
| Dec 31, 2022 | 30.72 Mn |
| Sep 30, 2022 | 30.60 Mn |
API Access
Neumora Therapeutics Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();